The effect of a structured intervention on caregivers of patients with dementia and problem behaviors: a randomized controlled pilot study

Alzheimer Disease and Associated Disorders
Alessandro NobiliGabriella Salvini Porro

Abstract

The objective was to assess the effect of a structured intervention on caregiver stress and the institutionalization rate of patients with dementia and problem behaviors. Caregivers contacting the Federazione Alzheimer Italia (AI) to receive help, advice, or information in relation to problem behaviors of outpatients were enrolled. Eligible caregiver-patient dyads were randomized to receive either a structured intervention or the counseling AI usually provides (control group). After basal assessment, families were reassessed at 6 and 12 months. Problem behavior (particularly agitation) was the only variable significantly correlated (P = 0.006) with the baseline caregivers' stress score. Thirty-nine families completed the 12-month follow-up; the mean problem behavior score was significantly lower in the intervention than the control group (p < 0.03); the time needed for care of the patient increased by 0.5 +/- 9.7 hours/day in the control group and decreased by 0.3 +/- 4.1 in the intervention group (p = 0.4, Wilcoxon test). The main determinant of institutionalization seemed to be the level of caregiver stress (p = 0.03). In patients of the intervention group, there was a significant reduction in the frequency of delusions. This...Continue Reading

References

Nov 1, 1975·Journal of Psychiatric Research·M F FolsteinP R McHugh
Nov 1, 1991·Neurology·A SpagnoliM Comelli
Apr 1, 1990·Journal of the American Geriatrics Society·E A MohideM Tew
Dec 2, 1989·BMJ : British Medical Journal·H Brodaty, M Gresham
Oct 1, 1985·Journal of the American Geriatrics Society·J KahanK Brummel-Smith
Oct 1, 1994·Archives of Psychiatric Nursing·K Robinson, K Yates
Dec 4, 1996·JAMA : the Journal of the American Medical Association·M S MittelmanB Levin
Jan 1, 1997·The British Journal of Psychiatry : the Journal of Mental Science·C DonaldsonA Burns
Jun 1, 1997·International Psychogeriatrics·K JuvaT Erkinjuntti
Jul 1, 1998·International Journal of Geriatric Psychiatry·C DonaldsonA Burns
Jan 7, 1999·Alzheimer Disease and Associated Disorders·B P ImbimboL J Thal
Jun 16, 1999·Alzheimer Disease and Associated Disorders·N W Kowall
Jun 16, 1999·Alzheimer Disease and Associated Disorders·C E Drebing
Sep 10, 1999·International Journal of Geriatric Psychiatry·M T González-SalvadorA C Barba
Jan 12, 2000·Dementia and Geriatric Cognitive Disorders·B P ImbimboF Lucchelli
Apr 23, 2002·JAMA : the Journal of the American Medical Association·Kristine YaffeKenneth E Covinsky
May 20, 2003·Journal of the American Geriatrics Society·Henry BrodatyAnnette Koschera
Sep 21, 1963·JAMA : the Journal of the American Medical Association·S KATZM W JAFFE
Feb 1, 1996·Cognitive Neuropsychiatry·A S David, P W Halligan

❮ Previous
Next ❯

Citations

Sep 1, 2005·Current Neurology and Neuroscience Reports·Dag AarslandClive Ballard
Jan 10, 2006·The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences·Martin Pinquart, Silvia Sörensen
May 24, 2011·Australian Occupational Therapy Journal·Sally BennettJacki Liddle
Jun 1, 2008·International Journal of Evidence-based Healthcare·Deborah ParkerJennifer Abbey
Feb 4, 2010·The Journal of Nutrition, Health & Aging·F NourhashémiB Vellas
Oct 27, 2009·Archives of Gerontology and Geriatrics·E RosaO Zanetti
Oct 16, 2007·Archives of Gerontology and Geriatrics·Lisbeth Villemoes SørensenGunhild Waldemar
Dec 6, 2005·The Psychiatric Clinics of North America·Richard SchulzJulie N Klinger
Mar 20, 2009·International Journal of Geriatric Psychiatry·Harald A NygaardJonn T Geitung
Jan 12, 2008·Journal of Advanced Nursing·Ercole VelloneMarlene Zichi Cohen
Apr 19, 2012·International Journal of Geriatric Psychiatry·Ellen B DennehyDenái R Milton
Nov 29, 2012·International Journal of Geriatric Psychiatry·Helen Tam-ThamBrenda R Hemmelgarn
Sep 3, 2011·International Journal of Older People Nursing·Anne Corbett, Clive Ballard
Nov 1, 2011·International Journal of Geriatric Psychiatry·Anne CorbettClive Ballard
Oct 16, 2013·Zeitschrift für Gerontologie und Geriatrie·S Voigt-RadloffM Hüll
Aug 18, 2016·Journal of Palliative Medicine·Adam E SingerKarl A Lorenz
Mar 28, 2008·American Journal of Alzheimer's Disease and Other Dementias·Michelle Devor, Marian Renvall
Nov 11, 2011·The Cochrane Database of Systematic Reviews·Myrra Vernooij-DassenMurna Downs
Oct 24, 2019·BMJ Open·Sofía García-SanjuánÁngela Sanjuan-Quiles
Jan 6, 2021·The American Journal of Occupational Therapy : Official Publication of the American Occupational Therapy Association·Sujatha E RajMandy Stanley

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.